Clinical Trial

RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies

Name: RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies — clinical trial record (NCT06267781)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRANSPLANTPRO

Recruiting

View on ClinicalTrials.gov →

Summary

To study whether highly effective therapies can halt disease progression in people with multiple sclerosis by modulating the peripheral myeloid landscape.

Trial Details

NCT Number	NCT06267781
Lead Sponsor	IRCCS San Raffaele
Conditions	Multiple Sclerosis
Enrollment	30 participants
Start Date	2022-09-02
Primary Completion	2027-09-02 (estimated)
Study Completion	2027-09-02 (estimated)
Updated on ClinicalTrials.gov	2024-02-20